|
|
Post by respect on Feb 9, 2018 7:11:47 GMT -5
Parexel acquired by Pamplona Management LLC in June of 2017 might be getting ready to give up its bay front ultra expensive real estate. Opportunities closer to more dense population centers has been the trend in newer and striving CRUs.
The rise of companies like Inflamax and Biotrial points the way. Tough and lean are the of the day. If Parexel can cut cost while leveraging its reputation it may be able to crush the new to the Tri State research facilities. Given BIOTRIAL poor safety records in the last 5 years(major trial injuries to subjects leaving one brain dead)a Parexel owned Pamplona move to the area is well worth the risk. Not to mention logistics,headquarters is in the New York area!
|
|
|
|
Post by rapunzel on Feb 9, 2018 9:54:05 GMT -5
Thx for the heads up!
|
|
|
|
Post by brandon on Feb 20, 2018 12:31:58 GMT -5
Where would they be going?
|
|
|
|
Post by respect on Feb 23, 2018 12:19:07 GMT -5
Where would they be going? Currently they have a unit in Maryland and California. Look for them to close at least one unit. Success of Biotrial in the Tri State area paying subjects below market could attract them to NY/NJ area. The over of bodies makes it a perfect fit to them. Alot of the viable subject pool at Parexel baltimore are already from the NY, NJ area so the move is well with in the imaginations. |
|
labrat1981
Junior Member
Posts: 99
I mainly do: Healthy Studies
|
Post by labrat1981 on Feb 23, 2018 18:03:11 GMT -5
Parexel acquired by Pamplona Management LLC in June of 2017 might be getting ready to give up its bay front ultra expensive real estate. Opportunities closer to more dense population centers has been the trend in newer and striving CRUs. The rise of companies like Inflamax and Biotrial points the way. Tough and lean are the of the day. If Parexel can cut cost while leveraging its reputation it may be able to crush the new to the Tri State research facilities. Given BIOTRIAL poor safety records in the last 5 years(major trial injuries to subjects leaving one brain dead)a Parexel owned Pamplona move to the area is well worth the risk. Not to mention logistics,headquarters is in the New York area! So no facts, just guesses..... |
|
|
|
Post by respect on Feb 27, 2018 10:13:52 GMT -5
Well as of now we know Baltimore is saying bye bye to non VCT studies. VCT is in!
|
|
|
|
Post by respect on Feb 27, 2018 10:14:44 GMT -5
Well as of now we know Baltimore is saying bye bye to non VCT studies. VCT is in!
|
|
